«

»

Reduction in Ephedra Poisonings after FDA Ban

To the Editor: Ephedra (ma huang) is an ephedra alkaloid botanical (primarily ephedrine and pseudoephedrine) with sympathomimetic activity. Ephedra can have a substantial effect on the cardiovascular and central nervous systems through direct adrenergic receptor agonism as well as indirect…

Read the full post at The New England Journal of Medicine: Search Results in Health Policy and Reform
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive